Literature DB >> 7037640

Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens.

M Kilian.   

Abstract

Attention has recently been focused on immunoglobulin A1 (IgA1) protease production as a possible virulence factor of bacteria implicated in meningitis and gonorrhea. This report demonstrates that suspected principal etiological agents in destructive periodontal disease include bacteria capable of degrading IgA1, IgA2, and IgG. Representative strains of Bacteroides melaninogenicus subsp. melaninogenicus and Capnocytophaga cleaved IgA1 but not IgA2 in the hinge region to yield intact Fab and Fc fragments. All Capnocytophaga strains also cleaved IgG in the same way. The majority of strains of Bacteroides asaccharolyticus and B. melaninogenicus subsp. intermedius caused complete degradation of both IgA1 and polyclonal IgG. However, some strains left the Fc part of IgA1 intact. Several strains were also capable of completely decomposing IgA2 and S-IgA. Significant IgA-cleaving enzyme activity was detected in whole subgingival dental plaque collected from patients with destructive periodontal disease. The results indicate that colonization of the subgingival area by B. asaccharolyticus, B. melaninogenicus, and Capnocytophaga spp. can induce a local paralysis of the immune defence mechanisms, thereby facilitating the penetration and spread of potentially toxic substances, lytic enzymes, and antigens released by the entire subgingival microflora.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037640      PMCID: PMC350936          DOI: 10.1128/iai.34.3.757-765.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Relationship of bacteria to the etiology of periodontal disease.

Authors:  S S Socransky
Journal:  J Dent Res       Date:  1970 Mar-Apr       Impact factor: 6.116

2.  Immunochemical comparison of proteins in human gingival pocket fluid, serum and saliva.

Authors:  P Brandtzaeg
Journal:  Arch Oral Biol       Date:  1965 Sep-Oct       Impact factor: 2.633

3.  Quantitative determination of immunoglobuline (IgG, IgA and IgM) and identification of IgA-type in the gingival fluid.

Authors:  K Holmberg; J Killander
Journal:  J Periodontal Res       Date:  1971       Impact factor: 4.419

4.  The effect of topical antigen on the gingiva of sensitized rabbits.

Authors:  W A McDougall
Journal:  J Periodontal Res       Date:  1974       Impact factor: 4.419

5.  Experimental gingivitis in man. 4. Vancomycin induced changes in bacterial plaque composition as related to development of gingival inflammation.

Authors:  S B Jensen; H Löe; C R Schiött; E Theliade
Journal:  J Periodontal Res       Date:  1968       Impact factor: 4.419

6.  Intestinal uptake of macromolecules. II. Effect of parenteral immunization.

Authors:  W A Walker; K J Isselbacher; K J Bloch
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

7.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  Immunoglobulins and complement in crevicular fluid, serum and saliva in man.

Authors:  E J Shillitoe; T Lehner
Journal:  Arch Oral Biol       Date:  1972-02       Impact factor: 2.633

9.  Intestinal uptake of macromolecules: effect of oral immunization.

Authors:  W A Walker; K J Isselbacher; K J Bloch
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

10.  Reactions in the periodontium to continuous antigenic stimulation in sensitized gnotobiotic rats.

Authors:  B Guggenheim; H E Schroeder
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

View more
  59 in total

1.  Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.

Authors:  E V Frandsen; M Kjeldsen; M Kilian
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 2.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

3.  Haemophilus influenzae immunoglobulin A1 protease genes: cloning by plasmid integration-excision, comparative analyses, and localization of secretion determinants.

Authors:  F J Grundy; A Plaut; A Wright
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

4.  Characterization of the immunoglobulin A protease of Ureaplasma urealyticum.

Authors:  R K Spooner; W C Russell; D Thirkell
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  Structural integrity of host defense factors in dental plaque.

Authors:  S D Hsu; M F Cole
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

6.  Monoclonal antibodies against surface antigens of Bacteroides gingivalis.

Authors:  Y Naito; K Okuda; T Kato; I Takazoe
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Sensitivity of Capnocytophaga species to bactericidal properties of human serum.

Authors:  M E Wilson; R Burstein; J T Jonak-Urbanczyk; R J Genco
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.

Authors:  J Mooney; E Adonogianaki; M P Riggio; K Takahashi; A Haerian; D F Kinane
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae.

Authors:  S R Hedges; M S Mayo; L Kallman; J Mestecky; E W Hook; M W Russell
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Effects of anaerobiosis and aerobiosis on interactions of human polymorphonuclear leukocytes with the dental plaque bacteria Streptococcus mutans, Capnocytophaga ochracea, and Bacteroides gingivalis.

Authors:  H L Thompson; J M Wilton
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.